|Videos|February 11, 2020
Elizabeth Gerard, MD: Genetic Testing in Adults With Epilepsy
Author(s)Elizabeth Gerard, MD
The associate professor of neurology and director of the Women With Epilepsy Program at Northwestern University Feinberg School of Medicine discussed the use of genetic testing in the adult epilepsy population.
Advertisement
“In our study, of 95 patients, we were able to give a diagnostic answer to 18 patients—that’s 19% of our adult population that we saw, specifically for genetic testing, that we were able to give an answer.”
As the field of genetics improves and interest in research and development in the field increases, the ability for medical professionals to take advantage of what it can provide has had a similar upward trajectory. One of the benefits is genetic testing, something that has grown in interest among patients.
In epilepsy, genetic testing has become an important diagnostic tool for physicians treating adult patients with epilepsy. One of those physicians is Elizabeth Gerard, MD, associate professor of neurology, and director, Women With Epilepsy Program, Northwestern University Feinberg School of Medicine, who has an adult epilepsy center at her institution. Over the past few years, they’ve offered this sort of testing for the adult population.
To find out more about what this program has uncovered and how this type of testing is helpful for physicians and their patients, NeurologyLive spoke with Gerrard.
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Related Articles
- Del-Zota Reverses Duchenne Disease Progression in 1-Year Trial Update
September 15th 2025
- 2025 Women in Neurology Conference: Educating, Mentoring, and Networking
September 15th 2025
- This Week on NeurologyLive® — September 15, 2025
September 15th 2025
- NeurologyLive® Brain Games: September 14, 2025
September 14th 2025
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive
1
MDA and PPMD Release Consensus Guidelines for Safe and Equitable Use of Gene Therapy in Duchenne
2
Del-Zota Reverses Duchenne Disease Progression in 1-Year Trial Update
3
10 Years of the Women Neurologists Group: A Preview of the 4th Annual Conference
4
This Week on NeurologyLive® — September 15, 2025
5